肝细胞移植作为治疗1a型糖原储存疾病的治疗方法
Lancet (London, England)
|February 7, 2002
概括
肝细胞移植为罕见的代谢障碍1a类型的糖原储存疾病提供了有前途的治疗方法. 这种创新疗法帮助患者实现了正常的代谢功能,并消除了禁食低血糖症.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 移植生物学 移植生物学
背景情况:
- 遗传性肝脏代谢障碍会带来重大治疗挑战.
- 葡萄糖储存疾病1a型 (GSD Ia) 由于葡萄糖的产生受损而表现为严重的禁食低血糖.
- 目前对GSD Ia的治疗选择有限,往往需要密集的饮食管理或肝移植.
研究的目的:
- 评估肝细胞移植作为治疗1a型糖原储存疾病的疗效.
- 评估肝细胞移植在GSD Ia患者的长期结果和安全性.
主要方法:
- 肝细胞移植包括通过门静脉导管输注20亿个可活性的肝细胞.
- 一种三重免疫抑制疗法,包括mycophenolate mofetil,tacrolimus和类固醇.
- 临床监测代谢参数,包括禁食低血糖和饮食耐受性.
主要成果:
- 该患者是一名47岁的女性,患有GSD Ia,在移植后经历了严重的禁食低血糖症的解决.
- 移植后9个月,患者可以保持正常的饮食和禁食7小时,没有低血糖发作.
- 通过降低免疫抑制疗法 (塔克罗利木斯单疗法) 实现了成功的管理.
结论:
- 肝细胞移植显示出作为治疗甘氨基储存疾病1a型的治愈治疗的潜力.
- 这种方法可能为GSD Ia患者提供肝移植的有价值替代方案.
- 需要进一步的研究来探索肝细胞移植在代谢性肝脏疾病中的更广泛适用性.
相关概念视频
Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...


